Furosemide Tablet
Product Images NDC 71335-2319

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 71335-2319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (76e87a12 C2c0 46dc 93e9 0c4d18373a79 01)

Chemical structure of furosemide, showing its molecular framework including a benzene ring with attached carboxyl, sulfonamide, chlorine, amine, and furan groups.*

FDA Label Image

Label (Lbl713352319)

Furosemide Tablets, USP 20 mg oral tablets label showing packaging for 30 tablets. The label highlights the product name, strength (20 mg), quantity (30 tablets), and dispensing information. It is repackaged by Bryant Ranch Prepack, Inc. and manufactured by Graviti Pharmaceuticals Private Limited. The label includes storage instructions, NDC 71335-2319-1, and safety warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.